Missed Out on Eli Lilly and Novo Nordisk? This Could Be the Next Big Weight Loss Stock.
https://www.fool.com/investing/2024/03/09/missed-out-on-eli-lilly-novo-nordisk-this-could/?source=iedfolrf0000001
Mar 09, 2024 - Viking Therapeutics has a promising anti-obesity treatment that is generating a lot of interest.
0
Eli Lilly said to have tapped National Resilience, BSP for Zepbound production
https://seekingalpha.com/news/4076137-eli-lilly-taps-national-resilience-bsp-make-zepbound?source=feed_sector_healthcare
Mar 05, 2024 - Eli Lilly (LLY) has inked deals with contract manufacturers National Resilience and BSP Pharmaceuticals to produce its weight loss drug Zepbound. Read more here.
0
The $1T club could soon have its first non-tech members: Berkshire Hathaway & Eli Lilly
https://seekingalpha.com/news/4074979-the-1t-club-could-soon-have-its-first-non-tech-members-berkshire-hathaway-eli-lilly?source=feed_sector_healthcare
Mar 02, 2024 - Berkshire Hathaway (BRK.A) (BRK.B) & Eli Lilly (LLY) could become the first non-tech companies to hit $1T in market cap. Read more here.
0
Is It Too Late to Buy Eli Lilly Stock Now?
https://www.fool.com/investing/2024/03/02/is-it-too-late-to-buy-eli-lilly-stock-now/?source=iedfolrf0000001
Mar 02, 2024 - Eli Lilly stock is having a moment, but the company could easily continue soaring.
0
4 stocks to watch on Friday: Plug Power, Eli Lilly and more
https://seekingalpha.com/news/4074559-4-stocks-to-watch-on-friday-plug-power-eli-lilly-and-more?source=feed_sector_healthcare
Mar 01, 2024 - Plug Power (PLUG), Eli Lilly (LLY), Microsoft (MSFT) and Warner Bros. Discovery (WBD) are the stocks to watch on Friday.
0
Top Analyst Reports for Eli Lilly, Procter & Gamble & Morgan Stanley
https://www.zacks.com/commentary/2232353/top-analyst-reports-for-eli-lilly-procter-gamble-morgan-stanley?cid=CS-ZC-FT-research_daily-2232353
Feb 27, 2024 - Today's Research Daily features new research reports on 16 major stocks, including Eli Lilly and Company (LLY), The Procter & Gamble Company (PG) and Morgan Stanley (MS).
0
Eli Lilly: Overvaluation Is A Big Red Flag
https://seekingalpha.com/article/4669991-eli-lilly-q4-earnings-overvaluation-big-red-flag?source=feed_all_articles
Feb 13, 2024 - Eli Lilly has strong financial performance with steady revenue growth and profitability expansion. Find out why LLY stock is a Sell.
0
Eli Lilly partner BioAge wins $170M to study Zepbound combo
https://seekingalpha.com/news/4066258-eli-lilly-partner-bioage-wins-170m-zepbound-combo-study?source=feed_sector_healthcare
Feb 13, 2024 - Biotech startup BioAge Labs raises $170M for Phase 2 trials for a combination therapy involving Eli Lilly's Zepbound and other weight loss drugs. Read more here.
0
Eli Lilly Just Succeeded Where Others Failed, but Does It Matter for the Stock?
https://www.fool.com/investing/2024/02/10/eli-lilly-just-succeeded-where-others-failed-but-d/?source=iedfolrf0000001
Feb 10, 2024 - Potentially adding billions of dollars in revenue might move the needle for the pharmaceutical giant, but that could take years.
0
Weight loss drugs are still hard to find — but Novo Nordisk and Eli Lilly are trying to change that
https://www.cnbc.com/2024/02/10/weight-loss-drugs-novo-nordisk-eli-lilly-are-tackling-supply-issues.html
Feb 10, 2024 - Novo Nordisk and Eli Lilly have given positive supply updates, aiming to reassure investors that they can continue to capitalize on the success of their drugs.
0